Post-earnings recap
Reported
Wed, May 3, 2023
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Castle Biosciences reported a larger-than-expected loss per share, which typically raises concerns among investors. However, the stock rose by 3.85% after the earnings announcement, indicating that investors may have found some positive aspects in the overall performance or future potential. Without guidance or additional commentary from management, it's difficult to assess the company's direction going forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-1.10 | N/A | -38.36% |
| Revenue | N/A | N/A | N/A |
No transcript is on record for this earnings call, so the analysis is based solely on numerical results.